GlassScriptPhysician profile
John Michael Douglass
NPI 1669734059
$1,011.70
in general payments reported to CMS, 2019-2025
17 companies · $176 in 2025
The $176 reported for 2025 was more than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $180 · 2020: $138 · 2021: $35.96 · 2022: $147 · 2023: $97.01 · 2024: $238 · 2025: $176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $511.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $511.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $168.56 | 2019-2024 | |
| Advanced Respiratory, INC | $146.97 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $120.45 | 2019-2025 | Eliquis |
| Merck Sharp & Dohme LLC | $117.91 | 2019-2024 | Dificid, Zerbaxa, Recarbrio |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $74.34 | 2020-2024 | Lifevest |
| Mallinckrodt Hospital Products INC. | $61.48 | 2022-2024 | Terlivaz |
| Abbvie INC. | $43.99 | 2024-2025 | |
| Dexcom, INC. | $43.94 | 2024-2025 | Dexcom G6 Transmitter |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $42.87 | 2024-2025 | Xifaxan |
| Vertex Pharmaceuticals Incorporated | $38.44 | 2025 | |
| Mindray Ds USA, INC. | $37.44 | 2022 | |
| Novartis Pharmaceuticals Corporation | $28.24 | 2019 | |
| Allergan, INC. | $21.83 | 2019 | |
| Melinta Therapeutics, LLC | $19.46 | 2019 | |
| Janssen Pharmaceuticals, INC | $17.40 | 2024 | Xarelto |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.29 | 2019 | |
| Bard Peripheral Vascular, INC. | $11.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Douglass listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.